Data Presented at the American Academy of Neurology Show XP13512/GSK1838262 Significantly Improved Symptoms of Moderate-to-Severe Primary Restless Leg... ( Additional Data Demonstrate Predicta...)

HOME >> MEDICINE >> TECHNOLOGY

Data Presented at the American Academy of Neurology Show XP13512/GSK1838262 Significantly Improved Symptoms of Moderate-to-Severe Primary Restless Legs Syndrome

Date:4/17/2008

Additional Data Demonstrate Predictable, Extended Exposure with Sustained-

Release Formulation

CHICAGO, April 17 /PRNewswire/ -- Data from the first pivotal study of XP13512/GSK1838262, a sustained-release investigational compound to treat Restless Legs Syndrome (RLS), showed that it significantly improved the symptoms of moderate-to-severe primary RLS compared to placebo, and was generally well-tolerated when administered once-daily for 12 weeks.

Data from the PIVOT RLS I (Patient Improvement in Vital Outcomes following Treatment for RLS) clinical trial, formerly designated as study XP052, were presented today at the 60th annual meeting of the American Academy of Neurology (AAN). The investigational compound is being developed by XenoPort (Nasdaq: XNPT) and GlaxoSmithKline (NYSE: GSK).

"This novel compound is the first non-dopaminergic agent to demonstrate efficacy in treating the symptoms of RLS in large controlled clinical trials," said Clete Kushida, M.D., director of the Stanford Center for Human Sleep Research and a clinical investigator in the PIVOT RLS I clinical trial.

Additional data presented at the meeting compared the pharmacokinetic profiles of an immediate-release formulation of XP13512, a sustained-release formulation of XP13512, and commercially-available gabapentin. The sustained- release formulation of XP13512, used in the PIVOT RLS I clinical trial presented at AAN, provided predictable and extended exposure in healthy volunteers compared with c
'/>"/>

SOURCE GlaxoSmithKline
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6
Related medicine technology :

1. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
2. Pre-clinical Data on Recent Advances with HIV VLP Vaccine Presented at AIDS Vaccine 07 Conference
3. New Study Presented at WorldSleep 2007 Demonstrates Ramelteon Has Sustained Efficacy Over Six Months in Adults With Chronic Insomnia
4. Genasense(R) Data in Melanoma to be Presented in Opening Session at First Worldwide Melanoma Center Meeting of the European Association of Dermato-Oncology
5. Ozarelix Phase 2 Data Presented at 29th Congress of the Societe Internationale dUrologie
6. GeoVax Successful HIV/AIDS Vaccine Trial Data Presented at AIDS Vaccine 2007 Conference
7. Study Results for Aclidinium Bromide, a Novel Anticholinergic, Presented at European Respiratory Society Annual Congress
8. Promising Data from Paratek Pharmaceuticals MAR Inhibitor Program Presented in Late Breaker Session at the 47th Interscience Conference on Antimicrobial Agents and Chemotherapy
9. New Phase III Data Presented for Once Monthly Dosing Regimen of Risedronate to Treat Postmenopausal Osteoporosis
10. Further Data on Safety and Efficacy of Cethromycin Presented at 47th Interscience Conference on Antimicrobial Agents and Chemotherapy
11. Further Data on Safety and Efficacy of Cethromycin Presented at 47th Interscience Conference on Antimicrobial Agents and Chemotherapy

Post Your Comments:

(Date:5/23/2013)... , May 23, 2013 The need to ... treatment continuum was highlighted prominently at the 108 ... Association (AUA), in San Diego. According to SonaCare ... focused ultrasound (HIFU) technology, the need for image-guided ... for urologists to consider minimally invasive ablative treatments, ...

(Date:5/23/2013)... 2013 Every day, their baby stopped breathing, his collapsed ... April and Bryan Gionfriddo watched helplessly, ... "Quite a few doctors said he had a good ... April Gionfriddo , about her now 20-month-old son, Kaiba. ... we would take it and run with it." ...

(Date:5/23/2013)... Mass. , May 23, 2013 Hologic, ... HOLX ), a leading developer, manufacturer and supplier ... products, with an emphasis on serving the healthcare ... large-scale observational study in a U.S. clinical practice ... technology (breast tomosynthesis) with conventional 2D mammography alone ...

Breaking Medicine Technology:Need for Image Guided Minimally Invasive Ablative Treatments Featured Prominently at American Urological Association (AUA) Annual Meeting 2 Need for Image Guided Minimally Invasive Ablative Treatments Featured Prominently at American Urological Association (AUA) Annual Meeting 3 Need for Image Guided Minimally Invasive Ablative Treatments Featured Prominently at American Urological Association (AUA) Annual Meeting 4 Need for Image Guided Minimally Invasive Ablative Treatments Featured Prominently at American Urological Association (AUA) Annual Meeting 5 Need for Image Guided Minimally Invasive Ablative Treatments Featured Prominently at American Urological Association (AUA) Annual Meeting 6 Baby's life saved with groundbreaking 3D printed device from U-M that restored his breathing 2 Baby's life saved with groundbreaking 3D printed device from U-M that restored his breathing 3 Baby's life saved with groundbreaking 3D printed device from U-M that restored his breathing 4 First Large-Scale Population-Based Study in the U.S. Shows Hologic's 3D Mammography (Breast Tomosynthesis) Significantly Reduces Recall Rates While Simultaneously Improving Cancer Detection 2 First Large-Scale Population-Based Study in the U.S. Shows Hologic's 3D Mammography (Breast Tomosynthesis) Significantly Reduces Recall Rates While Simultaneously Improving Cancer Detection 3 First Large-Scale Population-Based Study in the U.S. Shows Hologic's 3D Mammography (Breast Tomosynthesis) Significantly Reduces Recall Rates While Simultaneously Improving Cancer Detection 4

[0] Need for Image Guided Minimally Invasive Ablative Treatments Featured Prominently at American Urological Association (AUA) Annual Meeting [0] Baby's life saved with groundbreaking 3D printed device from U-M that restored his breathing [0] First Large-Scale Population-Based Study in the U.S. Shows Hologic's 3D Mammography (Breast Tomosynthesis) Significantly Reduces Recall Rates While Simultaneously Improving Cancer Detection

... (Nasdaq: LMNX ) announced today that management ... Stanley Global Healthcare Conference and the UBS Global Life ... York City. (Logo: http://photos.prnewswire.com/prnh/20100104/LUMINEXLOGO ) ... executive officer, will present at the Morgan Stanley Global ...

... H&P Industries, Inc., a manufacturer of OTC drug products ... the Chief Operating Officer,s (COO) role. ... Pharmaceutical and Biotechnology field to H&P mostly with Abbott ... and Validations to H&P as they begin to restart ...

Cached Medicine Technology:Luminex Corporation to Present at Upcoming Investment Conferences In September 2

Luminex Corporation to Present at Upcoming Investment Conferences In September H&P/TRIAD Hires Chief Operating Officer

(Date:5/25/2013)... Mansfield, MA (PRWEB) May 25, 2013 Imagine ... long -- the energy loss, hot air and wasted energy! ... whole house fan, a fireplace or clothes dryer, that may ... , Drafts from these often overlooked holes waste energy in ... source of heating and cooling loss in the home. , ...

(Date:5/25/2013)... Life science and analytical reagents are ... and create a new substance with the purpose of ... known as biotechnology reagents. Such reagents are significant in ... This market is driven by factors such as expansion ... therapeutics, growth in research and rapid commercialization of such ...

(Date:5/25/2013)... make great companions for senior citizens, but elderly people who ... more likely to crash than those who never drive with ... 2,000 licensed drivers aged 70 and older. The nearly 700 ... with their pet in the car. Among those who ... as high as among those who never drove with their ...

(Date:5/25/2013)... City Center, FL (PRWEB) May 25, 2013 ... is one of many of the NALA’s businesses throughout the ... Craig Amshel chose to participate in the nationwide event as ... as a Lieutenant Colonel in the Army. He said, “I ... in the community I serve, but I live here too.” ...

(Date:5/25/2013)... York, NY (PRWEB) May 25, 2013 ... dedicated to brain cancer research and advocacy, comments on ... Extraterrestrial Physics, that shows incorporating cold atmospheric plasma into ... cells. , According to a Science Daily ... Extraterrestrial Physics (MPE), biologists and physicians demonstrated the “synergistic ...

Breaking Medicine News(10 mins):Health News:How To Stop Drafts and Save On Home Energy Bills This Summer - New Draft Stoppers Now Available From Battic Door Energy Conservation 2 Health News:How To Stop Drafts and Save On Home Energy Bills This Summer - New Draft Stoppers Now Available From Battic Door Energy Conservation 3 Health News:How To Stop Drafts and Save On Home Energy Bills This Summer - New Draft Stoppers Now Available From Battic Door Energy Conservation 4 Health News:Life Sciences And Analytical Reagents Market - New Industry Research Report is Now Available for Pre-Order at Transparency Market Research 2 Health News:Life Sciences And Analytical Reagents Market - New Industry Research Report is Now Available for Pre-Order at Transparency Market Research 3 Health News:Seniors More Likely to Crash When Driving With Pet: Study 2 Health News:Dr. Craig Amshel of Absolute Surgical Specialists Offering Bowel Prep During the Shop Local for a Cause Event 2 Health News:Voices Against Brain Cancer Comments on Study that Shows Cold Plasma’s Success Against Brain Cancer Cells 2

[0] How To Stop Drafts and Save On Home Energy Bills This Summer - New Draft Stoppers Now Available From Battic Door Energy Conservation [0] Life Sciences And Analytical Reagents Market - New Industry Research Report is Now Available for Pre-Order at Transparency Market Research [0] Seniors More Likely to Crash When Driving With Pet: Study [0] Dr. Craig Amshel of Absolute Surgical Specialists Offering Bowel Prep During the Shop Local for a Cause Event [0] Voices Against Brain Cancer Comments on Study that Shows Cold Plasma’s Success Against Brain Cancer Cells

... Tenn. March 25, 2011) Ching-Hon Pui, M.D., a ... Children,s Research Hospital, is the recipient of the 2011 ... Clinical Research from the American Association for Cancer Research ... for Outstanding Achievement in Clinical Research is presented to ...

... ORLANDO, Fla. The American Association for Cancer Research ... contributed to progress in the fight against cancer at ... present an educational lecture at the meeting, which will ... Center. "We are honoring an exceptional group of ...

... Researchers at Mount Sinai School of Medicine have discovered ... may cause the most common inherited form of Parkinson,s ... journal Public Library of Science, shows that upon specific ... of proteins called 14-3-3, which has a regulatory function ...

... HealthDay Reporter , THURSDAY, March 24 (HealthDay News) ... and home-cooked foods rises, so, too, does body weight, ... 27 years. "Added sugars and body weight are ... the University of Minnesota School of Public Health, ...

... Jenifer Goodwin HealthDay Reporter , THURSDAY, March ... feeling of being at the park or the mall, ... parents of autistic children, those concerns can be even ... Alzheimer,s, autism experts say a tendency to wander is ...

... The ninth installment in the Berlin Open Access Conference ... funding, and policy communities around The Berlin Declaration on ... will take place at the Howard Hughes Medical Institute ... "Berlin 9 Open Access Conference: The impact of Open ...

Ching-Hon Pui, M.D., recognized with American Association for Cancer Research award AACR honors eminent researchers Mount Sinai finds promising clue to mechanism behind gene mutation that causes Parkinson's disease More Added Sugars, More Pounds?Dangerous Wandering a Lesser Known Side of Autism International Open Access meeting comes to the United States

... as thread-guide reducing time and trauma in ... is inserted into the nasolacrimal duct and ... it. The probe is then withdrawn leaving ... tubing in place. Canalicular Laceration or Imperforate ...

... prolene as thread-guide reducing time and trauma ... Probe is inserted into the nasolacrimal duct ... through it. The probe is then withdrawn ... silicone tubing in place. Newly coated with ...

For Canalicular Stenosis in Infants. Medical grade silicone. Note: Can also be used in DCR because of its high flexibility. Probe entirely embedded in silicone tubing (non-traumatic). Box of 3, steri...

For proper plug sizing....

Medicine Products:

Self-Threading MONOKA (Fayet-Bernard Ritleng Type, 3 mm COLLARETTE)Self-Threading MONOKA (Fayet-Bernard Ritleng Type, PVP coating)Infant Bika Punctal Gauges-Complete Set